Clinical Trial Update: Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing radiotherapy with cisplatin versus radiotherapy with cetuximab after induction chemotherapy for larynx preservation; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Laryngeal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Larynx Cancer, Hypopharynx Cancer | Phase 2 | Status: COMPLETED